ONVO News and Press, Organovo Holdings Inc. From 07/18/19

SAN DIEGO, July 18, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) will host a conference call on Thursday, August 8, 2019 at 5:00 p.m. Eastern Time (ET) to discuss the Company's fiscal first-quarter 2020 operating and financial highlights.  I...

SAN DIEGO, July 08, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range of serious diseases, presented data on fabricating stem cell-based kidney tiss...

SAN DIEGO, June 13, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range of serious adult and pediatric liver diseases, today announced that Chief Exec...

Organovo (NASDAQ: ONVO ) has  disclosed a partnership with the Murdoch Children’s Research Institute (MCRI), the Royal Children’s Hospital in Melbourne and the Leiden University Medical Center to develop 3D bioprinted stem cell-based therapeutic tissues to treat kidney disea...

ONVO stock is getting a lot of attention on Thursday as Organovo Holdings Inc (NASDAQ:ONVO) announcesd a collaboration with MCRI and Leiden University Medical Center to develop stem cell-based bioprinted tissue treatments for kidney disease. The San Diego, California based biotechn...

Organovo Holdings (NASDAQ: ONVO ) collaborates with Professor Melissa Little at the Murdoch Children's Research Institute (“MCRI”), The Royal Children’s Hospital, Melbourne, Australia and Ton Rabelink at Universiteit Leiden (“LUMC”), Leiden, Netherlands. ...

SAN DIEGO, May 30, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range of serious diseases, today announced a collaboration with Professor Melissa Lit...

Organovo Holdings, Inc. (ONVO) Q4 2019 Earnings Conference Call May 22, 2019 05:00 PM ET Company Participants Steve Kunszabo - Investor Relations Taylor Crouch - CEO Craig Kussman - CFO Conference Call Participants Ed Arce - H.C. Wainwright Matthew Cross - JonesTrading ...

Micro cap Organovo (NASDAQ: ONVO ) is off  11%  after hours in reaction to its preliminary fiscal Q4 results . Highlights: More news on: Organovo Holdings, Inc., Healthcare stocks news, Stocks on the move, Read more ...

- Pre-Investigational New Drug (“IND”) meeting with the FDA expected to be held in calendar 2020 - Submit first IND in calendar 2021 SAN DIEGO, May 22, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pi...